![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 16/2803 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/2827 | (2013.01) | ||
A61K 39/395 | (2006.01) | ||
A61K2039/507 | (2013.01) | ||
A61K2039/545 | (2013.01) |
(11) | Number of the document | 3697819 |
(13) | Kind of document | T |
(96) | European patent application number | 18807145.0 |
Date of filing the European patent application | 2018-10-18 | |
(97) | Date of publication of the European application | 2020-08-26 |
(45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/056442 |
Date | 2018-10-18 |
(87) | Number | WO 2019/079549 |
Date | 2019-04-25 |
(30) | Number | Date | Country code |
201762574073 P | 2017-10-18 | US |
(72) |
TAKIMOTO, Chris Hidemi, Mizufune , US
VOLKMER, Jens-Peter , US
CHAO, Mark, Ping , US
|
(73) |
Forty Seven, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
(54) | TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1 |
TREATMENT OF OVARIAN CANCER WITH ANTI-CD47 AND ANTI-PD-L1 |